Analytical Characterization for Similarity Assessment Between Biosimilar SB16 and Denosumab Reference Product Using State-of-the-Art Analytical Method.
- DOI
- 10.1007/s40268-026-00555-8
- Published
- 2026 Oct 23
- Container
- Drugs in R&D
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40268-026-00555-8,
title = {Analytical Characterization for Similarity Assessment Between Biosimilar SB16 and Denosumab Reference Product Using State-of-the-Art Analytical Method.},
author = {Jung E and Kim J and Do M and Kim J and Kweon H and Lee J and Lee J and Yoo T and Yang SY},
year = {2026},
journal = {Drugs in R\&D},
doi = {10.1007/s40268-026-00555-8},
url = {https://doi.org/10.1007/s40268-026-00555-8}
}RIS
TY - JOUR TI - Analytical Characterization for Similarity Assessment Between Biosimilar SB16 and Denosumab Reference Product Using State-of-the-Art Analytical Method. AU - Jung E AU - Kim J AU - Do M AU - Kim J AU - Kweon H AU - Lee J AU - Lee J AU - Yoo T AU - Yang SY PY - 2026 JO - Drugs in R&D DO - 10.1007/s40268-026-00555-8 UR - https://doi.org/10.1007/s40268-026-00555-8 ER -
APA
E, J., J, K., M, D., J, K., H, K., J, L., J, L., T, Y., & SY, Y. (2026). Analytical Characterization for Similarity Assessment Between Biosimilar SB16 and Denosumab Reference Product Using State-of-the-Art Analytical Method.. Drugs in R&D. https://doi.org/10.1007/s40268-026-00555-8
Source records
- pubmed · retrieved 2026-11-10T11:29:38.256Z
- europe-pmc · retrieved 2026-11-10T11:29:38.264Z